Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma.

Berndt SI, Huang WY, Chatterjee N, Yeager M, Welch R, Chanock SJ, Weissfeld JL, Schoen RE, Hayes RB.

Carcinogenesis. 2007 Sep;28(9):1965-70. Epub 2007 Jul 5.

PMID:
17615257
2.

Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma.

Berndt SI, Huang WY, Fallin MD, Helzlsouer KJ, Platz EA, Weissfeld JL, Church TR, Welch R, Chanock SJ, Hayes RB.

Cancer Res. 2007 Feb 1;67(3):1395-404.

3.

Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.

Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, Yeager M, Welch R, Bresalier RS, Weissfeld JL, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):306-11.

4.

Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.

Försti A, Li X, Wagner K, Tavelin B, Enquist K, Palmqvist R, Altieri A, Hallmans G, Hemminki K, Lenner P.

Genes Chromosomes Cancer. 2010 Mar;49(3):270-81. doi: 10.1002/gcc.20738.

PMID:
19998449
5.

Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma.

Huang WY, Chatterjee N, Chanock S, Dean M, Yeager M, Schoen RE, Hou LF, Berndt SI, Yadavalli S, Johnson CC, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):152-7.

6.

GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.

Moore LE, Huang WY, Chatterjee N, Gunter M, Chanock S, Yeager M, Welch B, Pinsky P, Weissfeld J, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1823-7.

7.

[Correlations of polymorphisms of TGFB1 and TGFBR2 genes to genetic susceptibility to gastric cancer].

Zhou Y, Jin GF, Jiang GJ, Wang HM, Tan YF, Ding WL, Wang LN, Chen WS, Ke Q, Shen J, Xu YC, Shen HB.

Ai Zheng. 2007 Jun;26(6):581-5. Chinese.

PMID:
17562261
8.

Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.

Peters U, Chatterjee N, Hayes RB, Schoen RE, Wang Y, Chanock SJ, Foster CB.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1144-54. doi: 10.1158/1055-9965.EPI-07-2947.

9.
10.

Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia.

Saltzman BS, Yamamoto JF, Decker R, Yokochi L, Theriault AG, Vogt TM, Le Marchand L.

Cancer Res. 2008 Feb 15;68(4):1236-44. doi: 10.1158/0008-5472.CAN-07-2144.

11.

Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.

Langdahl BL, Uitterlinden AG, Ralston SH, Trikalinos TA, Balcells S, Brandi ML, Scollen S, Lips P, Lorenc R, Obermayer-Pietsch B, Reid DM, Armas JB, Arp PP, Bassiti A, Bustamante M, Husted LB, Carey AH, Pérez Cano R, Dobnig H, Dunning AM, Fahrleitner-Pammer A, Falchetti A, Karczmarewicz E, Kruk M, van Leeuwen JP, Masi L, van Meurs JB, Mangion J, McGuigan FE, Mellibovsky L, Mosekilde L, Nogués X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Ioannidis JP; APOSS investigators.; DOPS investigators.; EPOS investigators.; EPOLOS investigators.; FAMOS investigators.; LASA investigators.; ERGO investigators.; GENOMOS Study..

Bone. 2008 May;42(5):969-81. doi: 10.1016/j.bone.2007.11.007. Epub 2007 Dec 3.

PMID:
18284942
12.

Insulin resistance-related genes and advanced left-sided colorectal adenoma.

Gunter MJ, Hayes RB, Chatterjee N, Yeager M, Welch R, Schoen RE, Yakochi L, Schatzkin A, Peters U.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):703-8.

13.

Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.

Daugherty SE, Platz EA, Shugart YY, Fallin MD, Isaacs WB, Chatterjee N, Welch R, Huang WY, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1536-42.

14.

Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake.

Han SS, Sue LY, Berndt SI, Selhub J, Burdette LA, Rosenberg PS, Ziegler RG.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):417-27. doi: 10.1158/1055-9965.EPI-11-0782. Epub 2012 Jan 17.

15.

Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.

Sansbury LB, Bergen AW, Wanke KL, Yu B, Caporaso NE, Chatterjee N, Ratnasinghe L, Schatzkin A, Lehman TA, Kalidindi A, Modali R, Lanza E.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):494-501.

16.

Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma.

Peters U, Chatterjee N, Yeager M, Chanock SJ, Schoen RE, McGlynn KA, Church TR, Weissfeld JL, Schatzkin A, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2181-6.

17.

DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.

Gao Y, Hayes RB, Huang WY, Caporaso NE, Burdette L, Yeager M, Chanock SJ, Berndt SI.

Carcinogenesis. 2011 Jun;32(6):882-7. doi: 10.1093/carcin/bgr071. Epub 2011 Apr 18.

18.

Risk factors for advanced colorectal adenomas: a pooled analysis.

Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, Jacobson JS, Fenoglio-Preiser CM, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):622-9.

19.

Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia.

Berndt SI, Huang WY, Yeager M, Weissfeld JL, Chanock SJ, Hayes RB.

Cancer Causes Control. 2009 May;20(4):487-90. doi: 10.1007/s10552-008-9274-y. Epub 2008 Dec 9.

20.

Genetic association and gene expression profiles of TGFB1 and the contribution of TGFB1 to otosclerosis susceptibility.

Priyadarshi S, Ray CS, Panda KC, Desai A, Nayak SR, Biswal NC, Ramchander PV.

J Bone Miner Res. 2013 Dec;28(12):2490-7. doi: 10.1002/jbmr.1991.

Supplemental Content

Support Center